The pharmaco‐economics of peri‐operative statin therapy
- 17 October 2005
- journal article
- Published by Wiley in Anaesthesia
- Vol. 60 (11) , 1059-1063
- https://doi.org/10.1111/j.1365-2044.2005.04371.x
Abstract
We analysed the pharmaco-economics of the prospective peri-operative studies of statin administration for major elective vascular surgery, using the NHS reference costs for 2004. This analysis suggests that peri-operative statin therapy for patients undergoing vascular surgery may present the most cost-effective use of statin therapy yet described, with a number-needed-to-treat of 15 and almost 60% of the total cost of atorvastatin therapy recovered through a reduction in peri-operative adverse events.Keywords
This publication has 39 references indexed in Scilit:
- Safety of perioperative statin use in high-risk patients undergoing major vascular surgeryThe American Journal of Cardiology, 2005
- Comparison of outcomes in acute coronary syndrome in patients receiving statins within 24 hours of onset versus at later timesThe American Journal of Cardiology, 2004
- Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trialPublished by Elsevier ,2004
- Preoperative Thallium Scanning, Selective Coronary Revascularization, and Long-Term Survival After Major Vascular SurgeryCirculation, 2003
- How cost-effective are new preventive strategies for cardiovascular disease?The American Journal of Cardiology, 2003
- Statins Are Associated With a Reduced Incidence of Perioperative Mortality in Patients Undergoing Major Noncardiac Vascular SurgeryCirculation, 2003
- Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)JAMA, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease PreventionCurrent Medical Research and Opinion, 2002
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998